Christopher M. Gorman
Christopher M. Gorman currently serves as Vice Chairman and President of Banking. In this role, Gorman
is responsible for KeyCorp’s businesses.Previously, Gorman was responsible for leading Key’s integration of First
Niagara Financial Group, a $40B financial institution with 400 branches throughout the northeastern U.S. Key’s
acquisition of First Niagara is the largest U.S. bank M&A transaction since the financial crisis and the largest
acquisition in Key’s 190-year history.
Prior to that, Gorman served as the President of Key Corporate Bank, which includes KeyBank Real Estate
Capital, Enterprise Commercial Payments, Key Equipment Finance and KeyBanc Capital Markets. Gorman has
been a member of KeyCorp's Executive Leadership Team, and President of the KeyBank Foundation Board of
Trustees since 2010. Additionally, he serves as Chairman of KeyCorp’s Corporate Responsibility Council.
Gorman is credited with building one of the first fully integrated Corporate and Investment Banks focused on the
middle market. Previously, Gorman led KeyBanc Capital Markets. He also held key leadership roles at McDonald
Investments, a registered broker-dealer acquired by KeyCorp in 1998.
Gorman is a member of The Financial Services Roundtable. He serves as a board member of University Hospital
Health System, Catholic Community Foundation of Cleveland and the Cleveland Museum of Art.
Previously, Gorman was a member of the Sisters of Charity Health Systems Board of Directors and served on the Executive Committee. Gorman also served as a Trustee of the Cleveland Institute of Music and The Zoological Society of Cleveland. He is the immediate past Chairman of Business Volunteers Unlimited and past Chairman of the KeyCorp United Way Services Campaign.
Gorman received a Bachelor’s Degree in Finance from Miami University. Gorman is a member of the Board of Visitors of Miami University’s Farmer School of Business.
2019 Greater Cleveland Golf Classic Honorary Chair & Honoree
Theodoros (Ted) Teknos, MD is President & Scientific Director for the University Hospitals Seidman Cancer Center
at University Hospitals Cleveland Medical Center and Deputy Director of the Case Comprehensive Cancer Center.
Dr. Teknos also has been appointed the Jane and Lee Seidman Chair in Cancer Innovation and he holds the title of
Clinical Professor at Case Western Reserve University School of Medicine. He is board certified in
Otolaryngology‐Head and Neck Surgery.
In his role as President & Scientific Director, Dr. Teknos leads the development of strategic, business and marketing
plans for UH Seidman, including cancer‐related palliative care, integrative care and interface with UH Hospice
care. He oversees all inpatient and ambulatory cancer care delivered at facilities across the UH system. Dr. Teknos
provides leadership of UH Seidman’s academic components and the Clinical Trials Unit and directs UH Seidman’s
involvement in the Case Comprehensive Cancer Center.
Dr. Teknos is a renowned clinician and academic authority in head and neck cancers, and he will continue his
surgical practice, clinical trials and research here at UH. Dr. Teknos has been published in over 200 peer‐reviewed
journals and publications, and he is a frequent presenter at major scientific meetings. He is active in numerous
professional societies, including the American Society of Clinical Oncology, the International Academy of Oral Oncology, the American Association for Cancer Research, and the American College of Surgeons. Dr. Teknos came to University Hospitals in October 2017 from The Ohio State University Wexner Medical Center, where he has served in several leadership roles since 2008. He served as Professor and Chair, Department of Otolaryngology – Head and Neck Surgery. Prior to his
position at Ohio State, he was Division Chief, Head & Neck Oncology Division, Department of Otolaryngology, at the University of Michigan Health System in Ann Arbor. From 2007 to 2014, Dr. Teknos co‐chaired a Task Force on Recurrent & Metastatic Disease for the National Cancer Institute’s Head & Neck Cancer Steering Committee.
Dr. Teknos earned his medical degree from Harvard Medical School. He completed his otolaryngology residency at Massachusetts Eye & Ear Infirmary/Harvard Combined Program, Boston, and a fellowship in head and neck oncology, skull base and microvascular reconstruction at Vanderbilt University Medical Center in Nashville.